Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620 |
Resumo: | Introduction: In this study, we reviewed a clinical series composed by all malignant lung lesions submitted to computed tomographyguided percutaneous thermal radiofrequency ablation, in our hospital, a rather recent technique that has been gaining scientific recognition.Material and Methods: For data purposes, all radiofrequency ablation and corresponding clinical records were retrospectivelyanalysed. A computed tomography scan was performed before and after each procedure to evaluate the tumour’s features, and at a second step to assess results and complications. The frequency of local recurrence and disease progression were determined based on imaging follow-up. Kaplan–Meier analysis was used to estimate survival. Univariate analysis recognized clinical and pathological factors affecting survival. These were also tested by multivariate analysis.Results: A total of 28 malignant lung lesions, 20 primary and 8 metastatic, from 28 patients (78.6% male; mean age 62 ± 17 years old), were submitted to computed tomography-guided radiofrequency ablation between January 2004 and July 2010. Total necrosis was achieved in 74.1% of the lesions. Immediate radiofrequency ablation-related complications were observed in half of the procedures. Among major complications, death occurred in one patient only. Median overall survival was 43.0 months for a mean 2-years follow-up.Median progression-free survival was 31.6 months. Lesion’s size smaller than 35 mm, stage III disease by the TNM classification and previous treatment attempts were significantly associated with better outcomes. Disease-related mortality was 46.4%.Discussion: This procedure proved to be efficient to treat lung cancerous lesions, with a low-rate of major complications.Conclusions: Computed tomography-guided percutaneous radiofrequency ablation is a minimally invasive procedure that appears to be valuable in the treatment of lung cancer lesions.Keywords: Catheter Ablation; Lung Neoplasms; Tomography, X-Ray Computed. |
id |
RCAP_a46d543b05107a5873507fe96b53e42f |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/5620 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer LesionsEficácia e Segurança da Termoablação Percutânea por Radiofrequência no Tratamento das Lesões Cancerígenas PulmonaresIntroduction: In this study, we reviewed a clinical series composed by all malignant lung lesions submitted to computed tomographyguided percutaneous thermal radiofrequency ablation, in our hospital, a rather recent technique that has been gaining scientific recognition.Material and Methods: For data purposes, all radiofrequency ablation and corresponding clinical records were retrospectivelyanalysed. A computed tomography scan was performed before and after each procedure to evaluate the tumour’s features, and at a second step to assess results and complications. The frequency of local recurrence and disease progression were determined based on imaging follow-up. Kaplan–Meier analysis was used to estimate survival. Univariate analysis recognized clinical and pathological factors affecting survival. These were also tested by multivariate analysis.Results: A total of 28 malignant lung lesions, 20 primary and 8 metastatic, from 28 patients (78.6% male; mean age 62 ± 17 years old), were submitted to computed tomography-guided radiofrequency ablation between January 2004 and July 2010. Total necrosis was achieved in 74.1% of the lesions. Immediate radiofrequency ablation-related complications were observed in half of the procedures. Among major complications, death occurred in one patient only. Median overall survival was 43.0 months for a mean 2-years follow-up.Median progression-free survival was 31.6 months. Lesion’s size smaller than 35 mm, stage III disease by the TNM classification and previous treatment attempts were significantly associated with better outcomes. Disease-related mortality was 46.4%.Discussion: This procedure proved to be efficient to treat lung cancerous lesions, with a low-rate of major complications.Conclusions: Computed tomography-guided percutaneous radiofrequency ablation is a minimally invasive procedure that appears to be valuable in the treatment of lung cancer lesions.Keywords: Catheter Ablation; Lung Neoplasms; Tomography, X-Ray Computed.Introdução: Neste estudo foram caracterizados e avaliados todos os tumores malignos do pulmão no nosso hospital submetidos a termoablação percutânea por radiofrequência guiada por tomografia computadorizada, uma técnica relativamente recente com crescente evidência científica.Material e Métodos: Os registos clínicos referentes a todas as termoablações percutâneas por radiofrequência realizadas na nossa instituição foram retrospectivamente analisados. Realizou-se uma tomografia computadorizada antes e depois de cada procedimento para avaliar as características do tumor e, numa segunda fase, para avaliar os resultados e complicações. A recorrência e progressão da doença foram determinados através do seguimento imagiológico. A análise Kaplan-Meier foi usada para calcular a sobrevivência. A análise univariada identificou os fatores clínicos e patológicos que afetaram a sobrevivência.Resultados: Um total de 28 lesões pulmonares malignas, 20 carcinomas primários e oito lesões metastáticas, de 28 doentes (78,6% do género masculino, com idade média de 62 ± 17 anos), foram submetidos a termoablação percutânea por radiofrequência entre janeiro de 2004 e julho de 2010. Obteve-se necrose total em 74,1% das lesões. Observaram-se complicações imediatas em metade dos procedimentos. Das principais complicações, ocorreu a morte em apenas um doente. A sobrevivência mediana global foi de 43,0 meses para uma média de dois anos de acompanhamento. A sobrevivência mediana sem progressão da doença foi de 31,6 meses. Osfatores que mostraram correlação estatisticamente significativa com melhores resultados foram: tamanho da lesão menor que 35 mm, doença no estádio III da classificação TNM e realização de tratamentos prévios. A mortalidade por progressão da doença foi de 46,4%.Discussão: Este procedimento provou ser eficaz no tratamento de lesões pulmonares cancerígenas, com uma baixa incidência de complicações graves.Conclusões: A termoablação percutânea por radiofrequência é um procedimento minimamente invasivo, que aparenta ser vantajoso no tratamento de lesões cancerígenas do pulmão.Palavras-chave: Ablação por Cateter; Neoplasias do Pulmão; Tomografia Computorizada.Ordem dos Médicos2015-02-27info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620oai:ojs.www.actamedicaportuguesa.com:article/5620Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 63-69Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 63-691646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/4238https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7479https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7480https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7540https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7591Tavares eCastro, AnaFreitas, SaraPortilha, AntóniaAlves, FernandoCaseiro-Alves, Filipeinfo:eu-repo/semantics/openAccess2022-12-20T11:04:25Zoai:ojs.www.actamedicaportuguesa.com:article/5620Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:08.290880Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions Eficácia e Segurança da Termoablação Percutânea por Radiofrequência no Tratamento das Lesões Cancerígenas Pulmonares |
title |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions |
spellingShingle |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions Tavares eCastro, Ana |
title_short |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions |
title_full |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions |
title_fullStr |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions |
title_full_unstemmed |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions |
title_sort |
Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions |
author |
Tavares eCastro, Ana |
author_facet |
Tavares eCastro, Ana Freitas, Sara Portilha, Antónia Alves, Fernando Caseiro-Alves, Filipe |
author_role |
author |
author2 |
Freitas, Sara Portilha, Antónia Alves, Fernando Caseiro-Alves, Filipe |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Tavares eCastro, Ana Freitas, Sara Portilha, Antónia Alves, Fernando Caseiro-Alves, Filipe |
description |
Introduction: In this study, we reviewed a clinical series composed by all malignant lung lesions submitted to computed tomographyguided percutaneous thermal radiofrequency ablation, in our hospital, a rather recent technique that has been gaining scientific recognition.Material and Methods: For data purposes, all radiofrequency ablation and corresponding clinical records were retrospectivelyanalysed. A computed tomography scan was performed before and after each procedure to evaluate the tumour’s features, and at a second step to assess results and complications. The frequency of local recurrence and disease progression were determined based on imaging follow-up. Kaplan–Meier analysis was used to estimate survival. Univariate analysis recognized clinical and pathological factors affecting survival. These were also tested by multivariate analysis.Results: A total of 28 malignant lung lesions, 20 primary and 8 metastatic, from 28 patients (78.6% male; mean age 62 ± 17 years old), were submitted to computed tomography-guided radiofrequency ablation between January 2004 and July 2010. Total necrosis was achieved in 74.1% of the lesions. Immediate radiofrequency ablation-related complications were observed in half of the procedures. Among major complications, death occurred in one patient only. Median overall survival was 43.0 months for a mean 2-years follow-up.Median progression-free survival was 31.6 months. Lesion’s size smaller than 35 mm, stage III disease by the TNM classification and previous treatment attempts were significantly associated with better outcomes. Disease-related mortality was 46.4%.Discussion: This procedure proved to be efficient to treat lung cancerous lesions, with a low-rate of major complications.Conclusions: Computed tomography-guided percutaneous radiofrequency ablation is a minimally invasive procedure that appears to be valuable in the treatment of lung cancer lesions.Keywords: Catheter Ablation; Lung Neoplasms; Tomography, X-Ray Computed. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-02-27 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620 oai:ojs.www.actamedicaportuguesa.com:article/5620 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/5620 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/4238 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7479 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7480 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7540 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7591 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 63-69 Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 63-69 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130642340904960 |